OpenVSafe by OpenVAERS
Search V-safe

8HQ-16100-25972

3 vaccinations 9 coded responses 35 check-ins 9 free-text entries 0 call cases
Sex
Male
Age at first dose
31-35
ZIP prefix
923 / CA
Registered
2021-04-22
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-22
    Registered in v-safe
  2. 2021-04-22
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-22
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-04-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-29
    Health check-in — day 7, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  11. 2021-05-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-13
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-05-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-05-20
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-05-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-10
    Survey response — day 28, dose 2
    MedDRA: Fatigue — Feeling: Good
    Free text: Fatigue. Difficult to wake up.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-06-17
    Survey response — day 35, dose 2
    MedDRA: Fatigue — Feeling: Good
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-06-24
    Survey response — day 42, dose 2
    MedDRA: Dry skin, Fatigue — Feeling: Good
    Free text: FatigueI've also noticed my hands have been dryer than normal.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-08-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-11-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-12-29
    Dose 3 — Pfizer-BioNTech
  28. 2021-12-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  29. 2021-12-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  30. 2022-01-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Swollen/tender lymph node. Supraclavicular.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-02
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Tender/swollen lymph nodes. Supraclavicular.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-01-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Fatigue or tiredness
    Free text: Swelling/tender lymph nodes. Supraclavicular. Less tender/swollen than past two days.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Arthralgia, Lymph node pain, Lymphadenopathy — Feeling: Good · Joint pains
    Free text: Swollen/tender lymph nodes. supraclavicular. Right shoulder pain.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-05
    Survey response — day 7, dose 3
    MedDRA: Arthralgia, Lymph node pain, Lymphadenopathy — Feeling: Good · Fatigue or tiredness
    Free text: Supraclavicular lymph nodes swollen/tender. Less than previous days. Light right shoulder pain.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-14
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-01-20
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-01-26
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-02-03
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-02-09
    Survey response — day 42, dose 3
    MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activities
    Free text: Some fatigue
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-22Pfizer-BioNTech
22021-05-13Pfizer-BioNTech
32021-12-29Pfizer-BioNTech No

Free text

Release 9 — day 28, dose 2

2021-06-10

Symptoms: Fatigue. Difficult to wake up.

Release 9 — day 35, dose 2

2021-06-17

Symptoms: Fatigue

Release 9 — day 42, dose 2

2021-06-24

Symptoms: FatigueI've also noticed my hands have been dryer than normal.

Release 10 — days 1–6 daily, dose 3

2022-01-01

Systemic reaction (other): Swollen/tender lymph node. Supraclavicular.

2022-01-02

Systemic reaction (other): Tender/swollen lymph nodes. Supraclavicular.

2022-01-03

Systemic reaction (other): Swelling/tender lymph nodes. Supraclavicular. Less tender/swollen than past two days.

2022-01-04

Systemic reaction (other): Swollen/tender lymph nodes. supraclavicular. Right shoulder pain.

Release 10 — day 7, dose 3

2022-01-05

Systemic reaction (other): Supraclavicular lymph nodes swollen/tender. Less than previous days. Light right shoulder pain.

Release 11 — day 42, dose 3

2022-02-09

Symptoms: Some fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDry skin ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SROArthralgia · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release